EAGLE Trial Shows ³ÉÈËBվ® CADDIEâ„¢ AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions Feb 2, 2026 ³ÉÈËBÕ¾ Announces U.S. Launch of the SecureFlexâ„¢ Single-Use Fine Needle Biopsy Device Jan 28, 2026 ³ÉÈËBÕ¾ Expands Voluntary Recall for ViziShot 2 FLEX (19G) EBUS -TBNA Needles Jan 16, 2026 ³ÉÈËBÕ¾ Triples Venture Capital Fund Investment to Strengthen MedTech Leadership Dec 14, 2025 ³ÉÈËBÕ¾ Announces Voluntary Corrective Action for the Single-Use Ligating Device Dec 5, 2025 ³ÉÈËBÕ¾, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States Dec 5, 2025 Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer Dec 2, 2025 Learning Opportunities Key for ³ÉÈËBÕ¾ Canada Employees Dec 2, 2025 ³ÉÈËBÕ¾ Corporation Announces Newest Appointments to Help Drive Innovation and Patient Safety for Respiratory Business Nov 11, 2025 ³ÉÈËBÕ¾ Unveils Corporate Strategy Nov 7, 2025 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
EAGLE Trial Shows ³ÉÈËBվ® CADDIEâ„¢ AI Solution Aids in the Detection of High-Risk and Hard-to-Detect Colorectal Lesions Feb 2, 2026
³ÉÈËBÕ¾, Gore, and ConMed Announce Transition of Commercial Support for the GORE® VIABIL® Biliary Endoprosthesis in the United States Dec 5, 2025
Swan EndoSurgical Appoints Veteran Robotics and MedTech Leader Erik Todd as Chief Executive Officer Dec 2, 2025
³ÉÈËBÕ¾ Corporation Announces Newest Appointments to Help Drive Innovation and Patient Safety for Respiratory Business Nov 11, 2025
